How soon after Wegovy does nausea start — and what to expect

Step 1, The first injection: what the first 48 hours usually feel like

The Wegovy titration schedule begins at 0.25 mg, a dose chosen specifically to let your body acclimatise. Even so, many people notice queasiness in the hours after their first injection. The mechanism is straightforward: semaglutide slows gastric emptying, meaning food sits in the stomach longer than usual. That delay is part of how the medicine reduces appetite, but it also means the stomach can feel full, heavy, or unsettled, and that sensation reads to the brain as nausea.

Timing matters practically. People who inject on a Monday morning (after a bigger weekend meal, perhaps) sometimes find it hits harder than those who inject midweek with a lighter diet. If you are planning around work, a social event, or anything requiring concentration, our page on how soon after a Wegovy injection side effects tend to appear can help you time things more precisely. Most people find symptoms are manageable with small, bland meals and keeping well hydrated, the practical guidance on managing Wegovy nausea goes into the day-to-day coping strategies in more detail.

By the end of the first week at 0.25 mg, the majority of people notice nausea has already softened. The NHS medicines page for semaglutide describes gastrointestinal side effects as common but typically short-lived at each dose level, and that matches what most patients report in clinical practice.

Step 2 (Each dose increase: why nausea can return in waves

The Wegovy schedule moves through five dose stages) 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, with roughly four weeks at each level before the prescriber moves you up. Nausea often follows this staircase pattern: it improves between increases, then resurfaces for a few days when the dose steps up. This is normal, and it is precisely why the titration is paced the way it is.

If you have found a dose increase harder than expected, the answer is almost never to miss the next injection or to push ahead faster, both routes carry their own problems. A conversation with your prescriber is the right call. You can read a broader account of when Wegovy side effects tend to start across the full range of symptoms.

The STEP 1 trial, published in the New England Journal of Medicine, recorded nausea as the most frequently reported side effect, with the highest incidence clustering around dose escalations. Most participants continued treatment successfully, it did not cause the majority to discontinue. That context is worth holding onto during a rough few days.

Step 3, When nausea is something to take seriously

Most Wegovy-related nausea is unpleasant but not dangerous. The signals to watch for are different in character: severe, persistent abdominal pain (especially pain that spreads to the back or does not ease within a few hours) should not be waited out. The MHRA's Drug Safety Update published in January 2026 highlighted acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. Pancreatitis pain tends to be more intense and constant than ordinary nausea, often accompanied by vomiting that does not relieve it. Seek urgent medical help if you experience that combination.

Signs of dehydration from repeated vomiting (dizziness, dark urine, rapid heartbeat, very little urination) also warrant prompt attention, as do any symptoms of a serious allergic reaction, swelling of the face, throat tightening, difficulty breathing. These are rare but real. If you experience something that worries you and it is not an emergency, you can contact your prescriber at our support team, who are available seven days a week. If it is urgent, call 111 or 999.

You can also report any suspected side effects directly to the MHRA through the Yellow Card scheme, this reporting genuinely contributes to the ongoing safety monitoring of medicines like Wegovy.

Putting it in perspective: what most people actually experience

Nausea is real, and we would not pretend otherwise. But clinical trial data and real-world prescribing both show that most people move through the titration schedule and settle at maintenance without the side effects defining their experience. By the time patients reach 2.4 mg, many find nausea has faded substantially, some stop noticing it at all.

Eating smaller portions, avoiding fatty or strongly spiced food around injection day, and staying hydrated make a meaningful difference for most people. The NHS guidance on semaglutide has a practical list of steps that can reduce gastrointestinal discomfort. Injecting at night so symptoms occur during sleep is a strategy some prescribers suggest, though the right approach for you is a conversation, not a rule.

If you are considering Wegovy and want to understand whether it is clinically suitable, our prescribers cover side effects, your medical history, and how to navigate dose changes as standard parts of the consultation. You can explore what treatment at nume involves on our Wegovy information page, or check how it compares with the wider range of weight-loss treatment options we offer. There is also a fuller account of how long Wegovy nausea typically lasts for those planning ahead.